<div class="container">

<table style="width: 100%;"><tr>
<td>computeN</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Estimation of Size and Numbers of Cases and Controls in the Target Population of Active Treatment Recipients At Risk at the Biomarker Sampling Timepoint</h2>

<h3>Description</h3>

<p>If the power calculation is done at the study design stage, the function estimates the size and numbers of cases and controls in the target population of active treatment recipients observed to be
at risk at the biomarker sampling timepoint.
</p>


<h3>Usage</h3>

<pre><code class="language-R">computeN(
  Nrand,
  tau,
  taumax,
  VEtauToTaumax,
  VE0toTau,
  risk0,
  dropoutRisk,
  propCasesWithS
)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>Nrand</code></td>
<td>
<p>the number of participants randomized to the active treatment group</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>tau</code></td>
<td>
<p>the biomarker sampling timepoint after randomization</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>taumax</code></td>
<td>
<p>the time after randomization marking the end of the follow-up period for the clinical endpoint</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>VEtauToTaumax</code></td>
<td>
<p>the treatment (vaccine) efficacy level between <code class="reqn">\tau</code> and <code class="reqn">\tau_{max}</code></p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>VE0toTau</code></td>
<td>
<p>the treatment (vaccine) efficacy between 0 and <code class="reqn">\tau</code></p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>risk0</code></td>
<td>
<p>the overall placebo-group endpoint risk between <code class="reqn">\tau</code> and <code class="reqn">\tau_{max}</code></p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>dropoutRisk</code></td>
<td>
<p>the risk of participant dropout between 0 and <code class="reqn">\tau_{max}</code></p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>propCasesWithS</code></td>
<td>
<p>the proportion of observed cases with a measured biomarker response</p>
</td>
</tr>
</table>
<h3>Details</h3>

<p>The function estimates design parameters that are required as input to <code>computePower</code>. If the power calculation is done after the follow-up was completed, the estimates are replaced by the observed
counterparts for use as input parameters in <code>computePower</code>.
</p>
<p>The calculations include options to account for participant dropout by specifying <code>dropoutRisk</code> as well as for incomplete sample storage by specifying <code>propCasesWithS</code>.
</p>
<p>The estimation procedure considers the standard survival analysis framework with failure and censoring times denoted by <code class="reqn">T</code> and <code class="reqn">C</code>, respectively, and makes the following assumptions:
</p>

<ol>
<li> <p><code class="reqn">T</code> and <code class="reqn">C</code> are independent.
</p>
</li>
<li> <p><code class="reqn">T|Z=0</code> follows an exponential distribution with rate <code class="reqn">\theta_t</code> and <code class="reqn">C|Z=0</code> follows an
exponential distribution with rate <code class="reqn">\theta_c</code>
</p>
</li>
<li> <p><code class="reqn">RR_{\tau-\tau_{max}} := P(T &lt;= \tau_{max}|T&gt; \tau, Z=1)/P(T &lt;= \tau_{max}|T&gt; \tau, Z=0)</code> is assumed to be equal to <code class="reqn"> P(T &lt;= t|T&gt; \tau, Z=1)/P(T &lt;= t|T&gt; \tau, Z=0)</code> for all <code class="reqn">t \in (\tau,\tau_{max}]</code>.
</p>
</li>
</ol>
<h3>Value</h3>

<p>A list with the following components:
</p>

<ul>
<li> <p><code>N</code>: the total estimated number of active treatment recipients observed to be at risk at <code class="reqn">\tau</code>
</p>
</li>
<li> <p><code>nCases</code>: the estimated number of clinical endpoint cases observed between <code class="reqn">\tau</code> and <code class="reqn">\tau_{max}</code> in the active treatment group
</p>
</li>
<li> <p><code>nControls</code>: the estimated number of controls observed to complete follow-up through <code class="reqn">\tau_{max}</code> endpoint-free in the active treatment group
</p>
</li>
<li> <p><code>nCasesWithS</code>: the estimated number of clinical endpoint cases observed between <code class="reqn">\tau</code> and <code class="reqn">\tau_{max}</code> in the active treatment group with an available biomarker response
</p>
</li>
</ul>
<h3>See Also</h3>

<p><code>computePower</code>
</p>


<h3>Examples</h3>

<pre><code class="language-R">Nrand = 4100
tau = 3.5
taumax = 24
VEtauToTaumax = 0.75
VE0toTau = 0.75/2
risk0 = 0.034
dropoutRisk = 0.1
propCasesWithS = 1
computeN(Nrand, tau, taumax, VEtauToTaumax, VE0toTau, risk0, dropoutRisk, propCasesWithS)

</code></pre>


</div>